Kelly Culwell - 20 May 2021 Form 4 Insider Report for Evofem Biosciences, Inc. (EVFM)

Role
Chief Medical Officer
Signature
/s/ Justin J. File, attorney-in-fact
Issuer symbol
EVFM
Transactions as of
20 May 2021
Net transactions value
-$36,172
Form type
4
Filing time
21 May 2021, 16:26:20 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVFM Common Stock Tax liability $36,172 -42,061 -13% $0.8600 273,390 20 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction.